Joint effect of platelet distribution width and stent surface area on major adverse cardiovascular events after percutaneous coronary intervention

被引:2
|
作者
Zhang, Xiaofeng [1 ,2 ]
Ge, Haiyan [3 ]
Gong, Xiaoxuan [1 ]
Wang, Jing [1 ]
Li, Chunjian [1 ]
机构
[1] Nanjing Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanjing, Peoples R China
[2] Nanjing Univ Chinese Med, Hosp Nanjing 2, Nanjing, Peoples R China
[3] Zhongshan Rehabil Hosp Jiangsu Prov, Dept Ultrasound, Nanjing, Peoples R China
关键词
Stent surface area(SSA); platelet distribution width (PDW); percutaneous coronary intervention (PCI); major adverse cardiovascular events (MACEs); DRUG-ELUTING STENTS; BARE METAL STENTS; ARTERY-DISEASE; MARKER; RISK;
D O I
10.21037/apm-21-1088
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: This study was conducted to analyze the influences of stent surface area (SSA), platelet distribution width (PDW), and the joint effect of these 2 risk factors on major adverse cardiovascular events (MACEs) in patients treated with percutaneous coronary intervention (PCI) together with drug-eluting stent (DES) implantation. Methods: Based on a cross-sectional survey conducted between 2011 and 2012, a prospective cohort study was enrolled consiting of 442 patients who had undergone PCI with DES implantation. We categorized the participants into 4 subgroups according to PDW and SSA. Cox proportional hazards models were applied to explore the correlation of PDW and SSA with MACE incidence. Results: During the 12 months of follow-up time, 87 patients experienced MACEs, which included 4 deaths (4.6%), 5 nonfatal myocardial infarctions (MIs) (5.75%), 9 ischemic strokes (10.34%), and 73 clinically relevant bleeding episodes (83.91%). The risks of MACEs were decreased by SSA and increased by PDW. However, the association of PDW or SSA with MACE was not statistically significant. Compared with the patients with PDW >= 13.5% and SSA <358.14 mm(2), the multivariable adjusted hazard ratios [HRs; 95% confience interval (CI)] of the total MACEs for the patients with PDW <13.5% and SSA >= 358.14 mm(2), and with PDW >= 13.5% and SSA >= 358.14 mm(2) were 0.94 (95% CI: 0.55-1.64) and 0.37 (95% CI: 0.18-0.76), respectively. Additionally, the patients in the group of PDW <13.5% and SSA <358.14 mm(2), and PDW >= 13.5% and SSA >= 358.14 mm(2) had respective HRs of 0.47 (95% CI: 0.24-0.91) and 0.28 (95% CI: 0.13-0.63) for 12-month bleeding events when PDW >= 13.5% and SSA <358.14 mm(2)was used as a group reference. Conclusions: Our present results suggest that the joint effect of PDW and SSA was significantly correlated to MACE development in the patients treated with PCI (with DES implantation).
引用
收藏
页码:5633 / 5640
页数:8
相关论文
共 50 条
  • [1] Prediction models for major adverse cardiovascular events after percutaneous coronary intervention: a systematic review
    Deng, Wenqi
    Wang, Dayang
    Wan, Yandi
    Lai, Sijia
    Ding, Yukun
    Wang, Xian
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 10
  • [2] Clot Strength and Platelet Reactivity for Prediction of Major Cardiovascular Events After Percutaneous Coronary Intervention
    Kwon, Osung
    Ahn, Jong-Hwa
    Koh, Jin-Sin
    Park, Yongwhi
    Hwang, Seok-Jae
    Kim, Sang-Wook
    Hwang, Jinyong
    Jeong, Young-Hoon
    CIRCULATION, 2022, 146
  • [3] Prediction of major adverse cardiac events after percutaneous coronary intervention
    Madan, Pankai
    Elayda, MacArthur
    Lee, Vei-Vei
    Wilson, James M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B54 - B55
  • [4] Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
    Chen, Zhihao
    Jiang, Chaohui
    Qu, Huimin
    Liang, Shuang
    Yang, Jian
    Wu, Hui
    He, Chao
    Wang, Xinan
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (06) : 1375 - 1380
  • [5] Association of depression with adverse cardiovascular events after percutaneous coronary intervention
    Wang, Zhi Jian
    Guo, Min
    Si, Tian Mei
    Jiang, Ming Ming
    Liu, Si Meng
    Liu, Yu Yang
    Zhao, Ying Xin
    Shi, Dong Mei
    Zhou, Yu Jie
    CORONARY ARTERY DISEASE, 2013, 24 (07) : 589 - 595
  • [6] Mean Platelet Volume and Major Adverse Cardiac Events following Percutaneous Coronary Intervention
    Nozari, Younes
    Parsa, Maziar
    Jalali, Arash
    Ariannejad, Hamid
    Shafiee, Akbar
    ARCHIVES OF IRANIAN MEDICINE, 2019, 22 (04) : 198 - 203
  • [7] Statin Effect on Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Patients on Hemodialysis
    Caturano, Alfredo
    Spiezia, Serenella
    Sasso, Ferdinando Carlo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 155 - 156
  • [8] Effect of Serum Fibrinogen, Total Stent Length, and Type of Acute Coronary Syndrome on 6-Month Major Adverse Cardiovascular Events and Bleeding After Percutaneous Coronary Intervention
    Mahmud, Ehtisham
    Ramsis, Mattheus
    Behnamfar, Omid
    Enright, Kelly
    Huynh, Andrew
    Kaushal, Khushboo
    Palakodeti, Samhita
    Li, Shiqian
    Teh, Phildrich
    Lin, Felice
    Reeves, Ryan
    Patel, Mitul
    Ang, Lawrence
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (10): : 1575 - 1581
  • [9] Major adverse cardiovascular and cerebral events in hypothyroid patients undergoing percutaneous coronary intervention
    Pasqualetti, Giuseppe
    Calsolaro, Valeria
    Monzani, Fabio
    JOURNAL OF THORACIC DISEASE, 2016, 8 (06)
  • [10] The Toronto risk score for major adverse cardiovascular events following percutaneous coronary intervention
    Ivanov, Joan
    Chowdhary, Saqib
    Horlick, Eric
    Seidelin, Peter
    Mackie, Karen
    Dzavik, Vlad
    CIRCULATION, 2006, 114 (18) : 842 - 842